Methodist Cancer Center — Omaha, Nebraska

Methodist Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Methodist Cancer Center has participated in 30 clinical trials.

Therapeutic areas: Kidney Cancer, Renal Cell Carcinoma, Small Cell Lung Cancer.

Sponsors: SCRI Development Innovations, LLC, Hoosier Cancer Research Network, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Methodist Cancer Center?

Methodist Cancer Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Methodist Cancer Center conducted?

Methodist Cancer Center has 30 clinical trials on record. Their work covers Kidney Cancer, Renal Cell Carcinoma, Small Cell Lung Cancer.

Is Methodist Cancer Center accredited by Crixeo Health?

Methodist Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Methodist Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.